Replies to post #483753 on Anavex Life Sciences Corp (AVXL)

[boi568]

I'll try to answer the Parkinson's trial start delay. Considering that Missling has been accurate in the past on deliverables when the date is just a couple of weeks away, what could possibly have happened in late January either at the company or at the FDA during those couple of weeks? (Hint: It wasn't a change of leadership at Anavex. Things seem normal at Anavex.)

[Hosai]

A lot of your points came down to "the company prospects must be bad coz the sp is low", however share prices don't always fairly reflect companies prospects.
On FDA approval in July 2024 Verona fell back to $15 and now 8 months later is at $65.60. You can never predict when things get priced in.

[williamssc]

Well ~24 million short shares keeping stock price in check doesn't help. Regardless of shorts, if AVXL progresses through the EMA process successfully, stockholders and humanity will benefit.

[Citrati]

Every one of those questions, IMO, has been answered ad nauseam recently except #6 and #10.

If that is truly the situation, my suggestion is for all of you to go ahead and sell. Two positives. The believers can buy more shares cheaper and the disgruntled can set aside their Xanax prescriptions.
Just my opinion for #10 conclusion not an actual recommendation. I am an unqualified anonymous internet poster with no credentials or professional standing. Buy or sell at your own risk after your own DD.

As for #6, if you look at institutional holdings, State Street Corp invests in many of the same bios as Baker Bro. However, they are not twins and both have holdings the other doesn't. I also don't consider Vanguard Group and Blackrock, lightweights. IMO, all 3 are heavyweights/Tier 1 institutions.

PS: add up their shares. Not insignificant holdings.

[Lacey1]

If the changes have to do with the new admi istratin. That's nothing but a plus for anavex.

[Hoskuld]

BAR123, no company can answer questions about share price - they are not in control of share price. And there are analysts with $40+ share price targets.

Squeaking is not going to get it done. They need to execute. And maybe they are doing so now. They filed the MAA, they expanded the 3-71 P2, and they are about to launch a properly sized trial for PD.

[bas2020]

The answer is simple... the price is controlled by the WS mob: HFs/MMs that work to manipulate the price of many stocks to maximize profits via created volatility. At this point with AVXL, leading up to approval, they and their institution buddies, will continue to manipulate and suppress the SP in order to shake loose shares and allow themselves to accumulate on the cheap. Their mission is to create a counter intuitive "reality" that creates FUD in retail holders' minds, causing them to sell.
To be a successful trader, one has to anticipate their moves and trade accordingly. Otherwise, one just needs to hold and accumulate lower.

[plexrec]

Bio---this should answer some of your questions--from Stocktwits board:
dnfrs
Yesterday 4:59 PM

$AVXL
FACT: Institutions have been buying.(over 40% now)
FACT: The JPAD peer reviewed article had 58 knowledgeable scientists sign it.
FACT: The OLE data was very positive. More to come.
FACT: EMA accepted the blarcamesine application (over 90% are approved)
FACT: In a few months Anavex 3-71 phase 2 Schizophrenia data will come.
FACT: EMA results by end of 2025
FACT: Submissions in UK, Canada and Australia expected by end 2025.
FACT: The general market is rocky.
FACT: Nothing Anavex can do about the general market.
FACT: Nothing Anavex can do about Institutions holding down stock to buy.
FACT: Many good biotechs are down.
But a lot of good news has come and a lot is coming.
I don't know a better stock to buy and hold!

1


29